Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06015672 · ClinicalTrials.gov registry record · NA

Accelerated TMS for Focal Hand Dystonia

A NA study of Isolated Focal Hand Dystonia, sponsored by Duke University.

Active
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT06015672 is a NA study of Isolated Focal Hand Dystonia that is active but no longer recruiting, run by Duke University. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06015672, a NA study of Isolated Focal Hand Dystonia, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on this, the current study administers four TMS sessions in a day, with assessments conducted in four weeks, twelve weeks, and 20 weeks after each session. The research involves 8 in-person and 6 virtual visits focused on functional MRI brain scans and writing behavior analysis. The potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in focal hand dystonia, paving the way for further advancements in clinical therapy for this condition.

Interventions

  • DEVICE Transcranial Magnetic Stimulation (TMS)

Study Locations (1)

North Carolina

  • Duke University Health System - Durham

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2023-12-21
Est. Completion 2027-02-05
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06015672

The ClinicalTrials.gov registry entry for NCT06015672 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Isolated Focal Hand Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.

NCT06015672 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06015672 about?

NCT06015672 is a clinical study titled "Accelerated TMS for Focal Hand Dystonia". This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on this, the current stu...

What is the current status of trial NCT06015672?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 21 participants. The study started on 2023-12-21. Estimated completion is 2027-02-05.

What conditions does trial NCT06015672 study?

This clinical trial studies the following conditions: Isolated Focal Hand Dystonia.

What interventions are being tested in trial NCT06015672?

The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).

Who is sponsoring clinical trial NCT06015672?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06015672 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.